Results 211 to 220 of about 1,206,543 (334)

Introducing the Team Card: Enhancing governance for medical Artificial Intelligence (AI) systems in the age of complexity. [PDF]

open access: yesPLOS Digit Health
Modise LM   +15 more
europepmc   +1 more source

Does Scanner Choice Matter for the Design of Foot Orthosis? [PDF]

open access: yesSensors (Basel)
Chhikara K   +11 more
europepmc   +1 more source

Social Engineering Exploits in Automotive Software Security: Modeling Human-targeted Attacks with SAM

open access: green, 2021
Matthias Bergler   +3 more
openalex   +2 more sources

Targeted Long‐Read Sequencing as a Single Assay Improves the Diagnosis of Spastic‐Ataxia Disorders

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The hereditary spastic‐ataxia spectrum disorders are a group of disabling neurological diseases. The traditional genetic testing pathway is complex, multistep and leaves many cases unsolved. We aim to streamline and improve this process using long‐read sequencing. Methods We developed a targeted long‐read sequencing strategy with the
Laura Ivete Rudaks   +20 more
wiley   +1 more source

Reconstitution of CXCR3+ CCR6+ Th17.1‐Like T Cells in Response to Ofatumumab Therapy in Patients With Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Ofatumumab, a fully human anti‐CD20 monoclonal antibody, is effective in reducing relapses and disability progression in patients with multiple sclerosis. This study aimed to examine immune profile changes associated with ofatumumab in a prospective cohort of Chinese patients with relapsing–remitting multiple ...
Shu Yang   +9 more
wiley   +1 more source

Relationship Between Gout Flare States and Patient‐Reported Outcomes After Allopurinol Initiation

open access: yesArthritis Care &Research, EarlyView.
Objective Gout flares are the most important clinical feature of the disease. A hypothetical maximum flare occurrence in the preceding six months has been suggested to be no flares for a patient‐acceptable symptom state (PASS) and only one flare for low disease activity (LDA).
Lisa K. Stamp   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy